Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
Abstract Background Endovascular revascularization has established as the first-line therapy of femoropopliteal artery disease. Paclitaxel-coated balloon angioplasty proved to be superior to plain old balloon angioplasty (POBA) regarding prevention of restenosis and need for recurrent revascularizat...
Main Authors: | Ulf Teichgräber, Maja Ingwersen, Stephanie Platzer, Thomas Lehmann, Thomas Zeller, René Aschenbach, Dierk Scheinert |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05631-9 |
Similar Items
-
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
by: Shigemitsu Shirai, et al.
Published: (2022-09-01) -
The effect of femoral and popliteal percutaneous transluminal balloon angioplasty on patients' quality of life
by: Ladislav Slovacek, et al. -
Paclitaxel-Coated Versus Sirolimus-Coated Eluting Balloons for Percutaneous Coronary Interventions: Pharmacodynamic Properties, Clinical Evidence, and Future Perspectives
by: Filippo Luca Gurgoglione, et al.
Published: (2024-11-01) -
RISK OF DEATH AFTER PACLITAXEL EXPOSURE DURING FEMOROPOPLITEAL ARTERY ANGIOPLASTY – NARRATIVE REVIEW
by: Tiago F. Ribeiro, et al.
Published: (2022-03-01) -
Successful Interventional Treatment of a Huge Pseudoaneurysm of the Popliteal Artery Caused by a Percutaneous Balloon Angioplasty Complication: A Case Report
by: Hyunmin Kim, et al.
Published: (2023-09-01)